Association between the examination rate of treatment‐resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study

• Main Authors: Norio Yasui‐Furukori (Author), Hiroyuki Muraoka (Author), Naomi Hasegawa (Author), Shinichiro Ochi (Author), Shusuke Numata (Author), Hikaru Hori (Author), Akitoyo Hishimoto (Author), Toshiaki Onitsuka (Author), Kazutaka Ohi (Author), Naoki Hashimoto (Author), Tatsuya Nagasawa (Author), Yoshikazu Takaesu (Author), Takahiko Inagaki (Author), Hiromi Tagata (Author), Takashi Tsuboi (Author), Chika Kubota (Author), Ryuji Furihata (Author), Jun‐ichi Iga (Author), Hitoshi Iida (Author), Kenichiro Miura (Author), Junya Matsumoto (Author), Hisashi Yamada (Author), Koichiro Watanabe (Author), Ken Inada (Author), Kazutaka Shimoda (Author), Ryota Hashimoto (Author)
• Format: Book
• Published: Wiley, 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background The decision to initiate clozapine treatment should be made on an individual basis and may be closely related to the early detection of treatment‐resistant schizophrenia (TRS), although there is evidence that the early use of clozapine results in a better response to treatment. T...